Suppr超能文献

国际实验室诊断肝素诱导血小板减少症的外部质量评估。

An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia.

机构信息

Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Greifswald, Germany.

Transfusion Medicine, Medical Faculty of Tübingen, Tübingen, Germany.

出版信息

J Thromb Haemost. 2019 Mar;17(3):525-531. doi: 10.1111/jth.14383. Epub 2019 Feb 20.

Abstract

Essentials A pilot study for External Quality Assessment for testing of HIT is described. The qualitative accordance for the PF4/heparin IgG test was 97.6%. The qualitative accordance for functional HIT tests was considerably lower. External Quality Assessment for functional HIT tests is required. SUMMARY: Objective Heparin-induced thrombocytopenia (HIT) is a potentially life-threatening complication of heparin exposure. Diagnosis is most reliable using a combination of an enzyme immunoassay (EIA) that detects antibodies against platelet factor 4 (PF4)/heparin complexes ("antigen" assay) and a "functional" assay that detects platelet-activating properties of the pathogenic HIT antibodies. No External Quality Assessment (EQA) is available for a combination of the tests. Here we report on the results of the first international EQA. Methods The pilot EQA was organized by the Department of Transfusion Medicine, Universitätsmedizin Greifswald, Germany. Six serum samples of patients, which were referred to Greifswald for HIT diagnosis, and one negative control sample were distributed to seven participants in Germany, Canada, and Singapore. Participants were asked to report the optical density (OD) values of their local EIA test for IgG-specific antibodies against the PF4/heparin complexes and the results for a functional assay (HIPA or SRA). Consensus was defined as a minimum 70% agreement, i.e., agreement among at least five of the seven participating laboratories. Results and conclusion Six out of seven participants reported results for EIA, with a high quantitative accordance (97.6%). For the functional assay, consensus was reached for all samples except the negative control, for which some participants reported nonspecific reactivity. All HIT-negative samples were correctly diagnosed by all participants; for HIT-positive samples, consensus of 70% was reached. Although the limited availability of sample material is an obstacle to overcome, an EQA combining both EIA and functional testing is feasible.

摘要

本研究旨在描述针对肝素诱导血小板减少症(HIT)检测的外部质量评估(EQA)的初步研究。PF4/肝素 IgG 检测的定性符合率为 97.6%。功能 HIT 检测的定性符合率则明显较低。因此,需要针对功能 HIT 检测进行 EQA。

摘要

目的肝素诱导的血小板减少症(HIT)是肝素暴露的一种潜在致命并发症。最可靠的诊断方法是结合酶免疫分析法(EIA)检测抗血小板因子 4(PF4)/肝素复合物的抗体(“抗原”检测)和检测致病性 HIT 抗体的血小板激活特性的“功能”检测。目前尚无针对这些检测组合的 EQA。在此,我们报告了首次国际 EQA 的结果。

方法

由德国格赖夫斯瓦尔德大学医学中心的输血医学系组织了该初步 EQA。将六份疑似 HIT 患者的血清样本和一份阴性对照样本分发给德国、加拿大和新加坡的七名参与者。参与者被要求报告其本地 EIA 检测 IgG 特异性抗 PF4/肝素复合物抗体的光密度(OD)值以及功能检测(HIPA 或 SRA)的结果。一致性定义为至少五家参与实验室之间的最小 70% 一致性。

结果和结论

七家参与实验室中有六家报告了 EIA 的结果,具有很高的定量一致性(97.6%)。对于功能检测,除了阴性对照样本外,所有样本都达成了共识,而对于一些参与者报告的非特异性反应,阴性对照样本未能达成共识。所有 HIT 阴性样本均被所有参与者正确诊断;对于 HIT 阳性样本,达到了 70%的一致性。尽管样本材料的有限可用性是一个需要克服的障碍,但同时结合 EIA 和功能检测的 EQA 是可行的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验